Kodiak Sciences IncNASDAQ:KOD
- LAST PRICE2.5300
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 2.5300
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | KOD |
|---|---|---|
| 09:32 ET | 1478 | 2.68 |
| 09:38 ET | 500 | 2.68 |
| 09:41 ET | 200 | 2.69 |
| 09:43 ET | 100 | 2.68 |
| 09:45 ET | 900 | 2.68 |
| 09:48 ET | 300 | 2.69 |
| 09:50 ET | 229 | 2.69 |
| 09:52 ET | 400 | 2.68 |
| 09:54 ET | 700 | 2.7 |
| 09:57 ET | 300 | 2.69 |
| 09:59 ET | 700 | 2.68 |
| 10:01 ET | 2484 | 2.67 |
| 10:03 ET | 100 | 2.67 |
| 10:06 ET | 500 | 2.67 |
| 10:10 ET | 300 | 2.67 |
| 10:12 ET | 4869 | 2.63 |
| 10:14 ET | 200 | 2.645 |
| 10:15 ET | 200 | 2.645 |
| 10:17 ET | 1700 | 2.64 |
| 10:19 ET | 1000 | 2.649 |
| 10:21 ET | 200 | 2.6401 |
| 10:24 ET | 500 | 2.65 |
| 10:28 ET | 1300 | 2.63 |
| 10:30 ET | 400 | 2.63 |
| 10:32 ET | 200 | 2.62 |
| 10:33 ET | 200 | 2.62 |
| 10:35 ET | 300 | 2.62 |
| 10:37 ET | 100 | 2.62 |
| 10:39 ET | 100 | 2.62 |
| 10:42 ET | 300 | 2.62 |
| 10:44 ET | 600 | 2.61 |
| 10:50 ET | 500 | 2.6 |
| 10:51 ET | 100 | 2.605 |
| 10:53 ET | 100 | 2.605 |
| 10:55 ET | 100 | 2.6 |
| 10:57 ET | 4897 | 2.61 |
| 11:00 ET | 1800 | 2.62 |
| 11:02 ET | 200 | 2.61 |
| 11:04 ET | 181 | 2.61 |
| 11:06 ET | 100 | 2.61 |
| 11:08 ET | 359 | 2.61 |
| 11:09 ET | 2200 | 2.61 |
| 11:11 ET | 100 | 2.62 |
| 11:13 ET | 456 | 2.615 |
| 11:15 ET | 100 | 2.62 |
| 11:20 ET | 374 | 2.615 |
| 11:22 ET | 200 | 2.61 |
| 11:24 ET | 446 | 2.615 |
| 11:27 ET | 300 | 2.615 |
| 11:29 ET | 736 | 2.615 |
| 11:31 ET | 100 | 2.615 |
| 11:33 ET | 438 | 2.615 |
| 11:36 ET | 300 | 2.61 |
| 11:40 ET | 431 | 2.61 |
| 11:44 ET | 516 | 2.61 |
| 11:47 ET | 870 | 2.61 |
| 11:49 ET | 709 | 2.61 |
| 11:51 ET | 500 | 2.6 |
| 11:54 ET | 409 | 2.6 |
| 11:58 ET | 200 | 2.59 |
| 12:00 ET | 506 | 2.59 |
| 12:03 ET | 406 | 2.59 |
| 12:07 ET | 500 | 2.59 |
| 12:09 ET | 1821 | 2.59 |
| 12:12 ET | 100 | 2.585 |
| 12:14 ET | 483 | 2.59 |
| 12:16 ET | 100 | 2.58 |
| 12:18 ET | 650 | 2.58 |
| 12:20 ET | 579 | 2.585 |
| 12:21 ET | 1300 | 2.59 |
| 12:23 ET | 684 | 2.585 |
| 12:25 ET | 9807 | 2.58 |
| 12:30 ET | 381 | 2.58 |
| 12:32 ET | 200 | 2.57 |
| 12:34 ET | 372 | 2.58 |
| 12:39 ET | 574 | 2.58 |
| 12:41 ET | 9899 | 2.57 |
| 12:43 ET | 370 | 2.56 |
| 12:45 ET | 1100 | 2.57 |
| 12:48 ET | 18129 | 2.54 |
| 12:50 ET | 590 | 2.54 |
| 12:52 ET | 14134 | 2.57 |
| 12:54 ET | 370 | 2.57 |
| 12:59 ET | 457 | 2.58 |
| 01:01 ET | 100 | 2.58 |
| 01:03 ET | 695 | 2.565 |
| 01:06 ET | 1100 | 2.56 |
| 01:08 ET | 264 | 2.555 |
| 01:10 ET | 376 | 2.555 |
| 01:12 ET | 8234 | 2.55 |
| 01:14 ET | 667 | 2.555 |
| 01:17 ET | 1610 | 2.545 |
| 01:24 ET | 377 | 2.545 |
| 01:26 ET | 3663 | 2.56 |
| 01:30 ET | 380 | 2.555 |
| 01:32 ET | 400 | 2.555 |
| 01:33 ET | 422 | 2.56 |
| 01:37 ET | 2000 | 2.5599 |
| 01:39 ET | 438 | 2.55 |
| 01:42 ET | 300 | 2.554 |
| 01:44 ET | 389 | 2.555 |
| 01:48 ET | 397 | 2.555 |
| 01:50 ET | 563 | 2.555 |
| 01:51 ET | 4394 | 2.564 |
| 01:53 ET | 5251 | 2.57 |
| 01:55 ET | 200 | 2.58 |
| 01:57 ET | 626 | 2.5703 |
| 02:00 ET | 490 | 2.58 |
| 02:02 ET | 300 | 2.58 |
| 02:04 ET | 740 | 2.575 |
| 02:08 ET | 100 | 2.58 |
| 02:09 ET | 420 | 2.575 |
| 02:11 ET | 291 | 2.57 |
| 02:13 ET | 430 | 2.575 |
| 02:15 ET | 132 | 2.58 |
| 02:20 ET | 425 | 2.575 |
| 02:22 ET | 200 | 2.57 |
| 02:24 ET | 423 | 2.575 |
| 02:26 ET | 200 | 2.58 |
| 02:27 ET | 400 | 2.58 |
| 02:29 ET | 428 | 2.585 |
| 02:31 ET | 700 | 2.58 |
| 02:33 ET | 867 | 2.575 |
| 02:38 ET | 100 | 2.575 |
| 02:40 ET | 658 | 2.57 |
| 02:42 ET | 927 | 2.57 |
| 02:44 ET | 445 | 2.565 |
| 02:47 ET | 1400 | 2.555 |
| 02:49 ET | 447 | 2.555 |
| 02:51 ET | 100 | 2.555 |
| 02:54 ET | 457 | 2.555 |
| 02:56 ET | 200 | 2.55 |
| 02:58 ET | 100 | 2.555 |
| 03:00 ET | 772 | 2.56 |
| 03:02 ET | 1087 | 2.555 |
| 03:03 ET | 1425 | 2.54 |
| 03:05 ET | 169 | 2.545 |
| 03:09 ET | 634 | 2.545 |
| 03:12 ET | 2630 | 2.53 |
| 03:14 ET | 525 | 2.535 |
| 03:16 ET | 100 | 2.53 |
| 03:18 ET | 1632 | 2.54 |
| 03:20 ET | 1048 | 2.55 |
| 03:23 ET | 576 | 2.555 |
| 03:27 ET | 437 | 2.555 |
| 03:30 ET | 541 | 2.55 |
| 03:32 ET | 400 | 2.554 |
| 03:34 ET | 787 | 2.555 |
| 03:36 ET | 100 | 2.555 |
| 03:38 ET | 100 | 2.56 |
| 03:39 ET | 1145 | 2.56 |
| 03:41 ET | 600 | 2.55 |
| 03:43 ET | 1291 | 2.555 |
| 03:45 ET | 750 | 2.5601 |
| 03:50 ET | 2006 | 2.57 |
| 03:52 ET | 2735 | 2.55 |
| 03:54 ET | 2000 | 2.555 |
| 03:56 ET | 6566 | 2.53 |
| 03:57 ET | 3900 | 2.53 |
| 03:59 ET | 8831 | 2.53 |
May 29, 2024
Kodiak Sciences to Present at Upcoming Investor and Clinical Conferences, from 4:36PM ET on Wednesday May 29, 2024 by Dow Jones
4:36PM ET on Wednesday May 29, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Kodiak Sciences Inc | 143.4M | -0.6x | --- |
Vigil Neuroscience Inc | 145.8M | -1.8x | --- |
Cytodyn Inc | 138.9M | -2.5x | --- |
XBiotech Inc | 138.3M | -4.8x | --- |
INmune Bio Inc | 149.0M | -3.7x | --- |
Yubo International Biotech Ltd | 140.2M | -115.3x | --- |
Company Information
Kodiak Sciences Inc. is a biopharmaceutical company. The Company has developed a new technology platform, the Antibody Biopolymer Conjugate (ABC) Platform, for retinal medicines. Its ABC Platform uses molecular engineering to merge the fields of protein-based and chemistry-based therapies. Its lead investigational medicine, tarcocimab, is a novel anti-vascular endothelial growth factor (anti-VEGF) antibody biopolymer conjugate under development for the treatment of high prevalence retinal vascular diseases, including diabetic retinopathy, the cause of blindness in working-age patients in the developed world, and wet age-related macular degeneration, the cause of blindness in elderly patients. Its second investigational medicine, KSI-501, is a bispecific antibody biopolymer conjugate targeting the pro-inflammatory cytokine interleukin-6 (IL-6) and VEGF. It is also developing a third investigational medicine, KSI-101, an unconjugated bispecific protein targeting IL-6 and VEGF.
Contact Information
- Headquarters
- 1200 PAGE MILL RDPALO ALTO, CA, United States 94304
- Phone
- 650-281-0850
- Fax
- 302-636-5454
Executives
- Chairman of the Board, Chief Executive Officer, Co-Founder
- Victor Perlroth
- Chief Financial Officer, Executive Vice President, Secretary
- John Borgeson
- Independent Director
- Robert Profusek
- Independent Director
- Felix Baker
- Independent Director
- Charles Bancroft
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $132.9M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 52.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.38 |
EPS | $-4.44 |
Book Value | $5.06 |
P/E Ratio | -0.6x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
